Shareholder alert: pomerantz law firm investigates claims on behalf of investors of acelrx pharmaceuticals, inc. (acrx)

New york, feb. 18, 2021 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of acelrx pharmaceuticals, inc. ("acelrx" or the "company") (nasdaq: acrx). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980....
ACRX Ratings Summary
ACRX Quant Ranking